Peter P. Swoboda, PhD

Consultant Cardiologist
Leeds Institute of Cardiovascular and Metabolic Medicine, United Kingdom

Peter Swoboda specialises in CMR research at the University of Leeds. He is leading several multicentre CMR researcrh projects including VENTOUX (in athletes with myocardial fibrosis), CE-MARC 3 (evaluation of new onset suspected angina) and CROSS-HF (imaging in heart failure). He has published over 100 CMR papers and this will be his 10th year attending SCMR.

Presentation(s):

• Prognostic significance of quantitative perfusion by cardiovascular magnetic resonance in dilated cardiomyopathy

  Thursday, January 30, 2025
  11:00 AM – 11:10 AM East Coast USA Time

• Myocardial blood flow quantification in patients with heart failure with and without left bundle branch block (RF_TH_266)

  Thursday, January 30, 2025
  5:40 PM – 5:50 PM East Coast USA Time

• Impact of Age and Sex on Myocardial Involvement in hospitalized COVID-19 patients: A Pre-specified Subanalysis of COVID-HEART (RF_FR_331)

  Friday, January 31, 2025
  11:00 AM – 11:10 AM East Coast USA Time

• Cardiac Magnetic Resonance Assessment of Left Atrial Fibrosis in Veteran Endurance Athletes (VENTOUX-AF)

  Saturday, February 1, 2025
  8:40 AM – 8:50 AM East Coast USA Time

• The relationship between ischaemia burden and exercise time: A CE-MARC sub study (RF_SA_442)

  Saturday, February 1, 2025
  9:40 AM – 9:50 AM East Coast USA Time

• A pragmatic approach to the investigation of stable chest pain: a UK, multi-center, randomized trial to improve patient outcomes, quality of life and cost effectiveness (CE-MARC 3) (RF_SA_499)

  Saturday, February 1, 2025
  10:50 AM – 11:00 AM East Coast USA Time